SLDB
Solid Biosciences Inc.NASDAQHealthcare$7.74+3.34%ClosedMarket Cap: $603.0M
As of 2026-04-07
Valuation
P/E (TTM)
—
PEG
—
P/B
4.07
P/S
0.00
EV/EBITDA
-3.27
DCF Value
$0.41
FCF Yield
-26.1%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-73.3%
ROA
-75.0%
ROIC
-89.1%
Income Statement
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q4 2025 | $0.00 | -Infinity% | $-49.4M | $-49.8M | $-0.53 | — |
| FY 2025 | $0.00 | -Infinity% | $-179.2M | $-174.3M | $-1.99 | — |
| Q3 2025 | $0.00 | NaN% | $-48.1M | $-45.8M | $-0.48 | — |
| Q2 2025 | $0.00 | -Infinity% | $-41.7M | $-39.5M | $-0.42 | — |
| Q1 2025 | $0.00 | -Infinity% | $-40.1M | $-39.3M | $-0.59 | — |
| Q4 2024 | $0.00 | NaN% | $-39.9M | $-42.6M | $-0.80 | — |
| FY 2024 | $0.00 | -Infinity% | $-129.7M | $-124.7M | $-3.06 | — |
| Q3 2024 | $0.00 | NaN% | $-35.2M | $-32.7M | $-0.79 | — |
| Q2 2024 | $0.00 | NaN% | $-27.8M | $-25.1M | $-0.61 | — |
| Q1 2024 | $0.00 | -Infinity% | $-26.9M | $-24.3M | $-0.64 | — |
| Q4 2023 | $0.00 | NaN% | $-22.3M | $-20.3M | $-0.70 | — |
| FY 2023 | $0.00 | -Infinity% | $-104.3M | $-96.0M | $-4.83 | — |